GUD's stake in SNYR is 19.8%, new filingValue Digger, one of the best Seeking Alpha authors who is ranked in TOP-100 among all the financial analysts and bloggers worldwide, wrote an article about SNYR a few days ago, its brands and how absurdly cheap it is relative to the peers, see below:
Synergy CHC (SNYR): Unknown, Cheap, Profitable Growth Stock with Hot And Innovative Brands Meanwhile, Knight Therapeutics's (GUD) stake is 19.8% based on the latest filing, see SNYR's website:
https://client.irwebkit.com/synergychc/